Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001104659-25-013643·Contineum Therapeutics, Inc.
Schedule 13G ownership disclosure
Contineum Therapeutics Inc
Class A Common Stock · CUSIP: 21217B100
Event date: 2024-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Sectoral Asset Management Inc
Shares: 800,787.00 · Class: 4.2%
- Jerome G. Pfund
Shares: 950,786.00 · Class: 4.99%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-25-013643
- Form type
- SCHEDULE 13G/A
- Filer
- Contineum Therapeutics, Inc.
- CIK
- CIK 1855175
- Filed
- Feb 14, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership